Tag: whistleblower
Jury finds Eli Lilly liable for defrauding Medicaid, must pay $61M in damages
Aug 5, 2022. More than eight years after a former pharmacist sued Eli Lilly, Bristol Myers Squibb and other drugmakers for allegedly skimping out on Medicaid rebates, Lilly’s day in court has finally come. Now, a jury has found the Indianapolis-based company liable for defrauding the nation’s Medicaid program and ordered it to shell out $61 million in damages. Because the damages are trebled under the False Claims Act, meanwhile, the final judgement will exceed $183 million, the law firm…
DOJ Opens Probe Into Falsified Data Allegations Against Cassava
Jul 27, 2022. The United States Department of Justice has opened an investigation into the Austin, Texas-based Cassava Sciences regarding allegations that the company falsified data to support Simufilam, its drug candidate for Alzheimer’s disease. The probe could swing both ways, leading to criminal charges or end with no resulting lawsuit. The probe, revealed in an exclusive report by Reuters, will be led by investigators experienced in determining whether or not entities have defrauded consumers, investors or government agencies, according…
Biogen Quietly Resolves Whistleblower Case for $900M
Jul 21, 2022. Along with axing a Phase II schizophrenia program and touting the potential of lecanemab, its next shot at Alzheimer’s disease, Biogen announced Wednesday that it is forking over $900 million to resolve a lawsuit. The whistleblower claim was brought by former employee Michael Bawduniak, who accused the company of paying off doctors to favor its multiple sclerosis drugs over those of its competitors. The trial for this case was scheduled to begin July 26. The payment, quietly…
Aerojet Rocketdyne Whistleblower To Receive $2.61 Million in False Claims Act Settlement
July 13, 2022. DOJ Press Release. Brian Markus, a former employee at Aerojet Rocketdyne Inc., will be awarded $2.61 million for his role as a qui tam whistleblower in a False Claims Act case. In the U.S. Department of Justice’s (DOJ) press release, two U.S. Attorneys highlighted the importance of whistleblowers in cybersecurity enforcement. The qui tam provisions of the False Claims Act enable private citizens to file lawsuits on behalf of the government if they know of an individual…
Eli Lilly whistleblower fired after reporting manufacturing problems at NJ plant
Jun 6, 2022. A former human resources officer at Eli Lilly and Co sued the drugmaker on Monday, alleging she was terminated after pointing out poor manufacturing practices and data falsification involving one of its blockbuster diabetes drugs. The plaintiff, Amrit Mula, alleges violations of an employee protection law and seeks unspecified damages. The U.S. Department of Justice last year launched a criminal investigation into alleged manufacturing irregularities at an Eli Lilly plant in New Jersey following a Reuters story…
